Level-based news learning
Read news in four smart levels.
Search, sort, and open stories with simplified vocabulary and keyword-rich pages.
Aktif Etiket Filtresi: #clinical trial
CNN
• Oct 24, 2026
Personalized mRNA Vaccine Cuts Melanoma Risk Personalized mRNA Vaccine Cuts Melanoma Risk Personalized mRNA Vaccine Cuts Melanoma Risk Personalized mRNA Vaccine Cuts Melanoma Risk
A new personalized mRNA vaccine from Merck and Moderna reduced melanoma recurrence by 42% in a recent trial. A new personalized mRNA vaccine from Merck and Moderna reduced melanoma recurrence by 42% in a recent trial. A new personalized mRNA vaccine from Merck and Moderna reduced melanoma recurrence by 42% in a recent trial. A new personalized mRNA vaccine from Merck and Moderna reduced melanoma recurrence by 42% in a recent trial.